The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagyMao‐xu Ge, Rong‐Guang Shao|British Journal of Pharmacology|2017Cited by 65
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamstersMao‐xu Ge, Hongwei He|Acta Pharmacologica Sinica|2018Cited by 37